Artificial intelligence infrastructure startup Lambda Inc. today announced that it has closed a late-stage funding round worth more than $1.5 billion. TWG Global, a holding company led by billionaire ...

AI data center provider Lambda announced Tuesday it raised $1.5 billion in a round led by TWG Global, a relatively new $40 billion investment firm formed by billionaires Thomas Tull, the former owner ...

AI cloud startup Lambda announced a multibillion-dollar partnership with Microsoft to build AI infrastructure powered by Nvidia chips. The Nvidia-backed firm has had a relationship with Microsoft ...

Monoclonal gammopathy subtypes, especially IgM-MG, define distinct clinical subsets in CLL, impacting therapeutic outcomes significantly. IgM-MG is linked to poorer prognostic indicators, including ...

Cloud provider Lambda might be following rival CoreWeave to the public markets. Lambda, an AI infrastructure company offering on-demand GPUs, has hired banks for an upcoming IPO, according to ...

A systematic diagnostic approach should be used to differentiate AAV from multiple myeloma. An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody ...

Lambda Labs Inc., a startup with a cloud platform optimized to run artificial intelligence models, today announced that it has raised $480 million from investors. The Series D round reportedly values ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the AI Developer Cloud, today announced it has raised a $480 million Series D, bringing the total equity capital raised to date to $863 million. The round ...

AWS Lambda celebrated its tenth anniversary in November 2024, marking a decade of transforming cloud computing through serverless architecture. By eliminating the need for infrastructure management, ...

Case: A 52-yr-old man with weight loss and urinary hesitancy for 4 months underwent a CT urogram. No urologic abnormalities were noted but there was an incidental finding of intraperitoneal nodules ...

BOSTON, July 17, 2024 /PRNewswire/ -- Immunocan announced the successful construction of new strain of fully human antibody platform: ImmuMab® HKL mouse. This new mouse was created by in-situ ...